Advance Agrolife

Why is Advance Agrolife Ltd falling/rising?

As of 01-Sep, Advance Agrolife Ltd's stock price is rising to 116.60, indicating a potential recovery in investor sentiment after a trend reversal. This increase is supported by strong financial results, including a 202.28% growth in net profit, and increased institutional investor interest.

As of 01-Sep, Advance Agrolife Ltd's stock price is rising, currently at 116.60, reflecting a change of 0.65 (0.56%) upward. This increase follows a trend reversal after three consecutive days of decline, indicating a potential recovery in investor sentiment. The stock has outperformed its sector by 0.39% today, suggesting that it is gaining traction compared to its peers.<BR><BR>Despite a recent decline in stock performance over the past week and month, where it fell by 2.67% and 6.76% respectively, the company's strong financial results have contributed to the positive movement in its stock price. Notably, the company reported a remarkable growth in net profit of 202.28% in its latest quarterly results, with a profit after tax of Rs 22.55 crore, which is a significant increase compared to the previous four-quarter average. Additionally, the company's operating profit to interest ratio is at its highest, indicating robust financial health.<BR><BR>Moreover, institutional investors have shown increased interest, raising their stake by 1.4% in the last quarter, which reflects confidence in the company's fundamentals. This growing participation from institutional investors can positively influence the stock price as they typically have more resources to analyze and support the company's long-term growth.<BR><BR>Overall, the combination of strong financial performance, a trend reversal after previous declines, and increased institutional investment are key factors contributing to the rise in Advance Agrolife Ltd's stock price.

What does Advance Agrolife do?

Advance Agrolife Ltd is a micro-cap company in the pesticides and agrochemicals industry, reporting net sales of 330 Cr and a net profit of 23 Cr for June 2026. Key financial metrics include a P/E ratio of 15.00 and a market cap of INR 749 Cr.

Overview: <BR>Advance Agrolife Ltd operates in the pesticides and agrochemicals industry and is categorized as a micro-cap company.<BR><BR>History: <BR>The incorporation year and any status changes are not available. The latest quarterly results reported are for June 2026, showing net sales and profit.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 330 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: 23 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 749 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 15.00 <BR>Industry P/E: 26 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.07 <BR>Return on Equity: 15.78% <BR>Price to Book: 2.44 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: Not available. <BR>Email: Not available. <BR>Website: Not available.

Who are the peers of the Advance Agrolife?

Peers of Advance Agrolife include India Pesticides, Meghmani Organics, Punjab Chemicals, Astec Lifesciences, Dharmaj Crop, Heranba Industries, Best Agrolife, Shivalik Rasayan, and Crop Life Sciences. Management risk varies from excellent to below average among peers, with Meghmani Organics showing the highest 1-year return at -21.90% and Heranba Industries the lowest at -51.21%.

Peers: The peers of Advance Agrolife are India Pesticides, Meghmani Organi., Punjab Chemicals, Astec Lifescienc, Dharmaj Crop, Heranba Inds, Best Agrolife, Shivalik Rasayan, and Crop Life Scienc.<BR><BR>Quality Snapshot: Excellent management risk is observed at Best Agrolife and Shivalik Rasayan, while Average management risk is found at India Pesticides, Punjab Chemicals, Dharmaj Crop, and Crop Life Scienc, and the rest. Below Average management risk is noted at Meghmani Organi., Astec Lifescienc, Heranba Inds, and Shivalik Rasayan. Growth is rated as Good for Dharmaj Crop, Below Average for India Pesticides, Meghmani Organi., Punjab Chemicals, Astec Lifescienc, Heranba Inds, Best Agrolife, and Crop Life Scienc, and the rest. Average capital structure is seen at Meghmani Organi., Best Agrolife, and Crop Life Scienc, while Good capital structure is noted at Punjab Chemicals and Dharmaj Crop, and Excellent capital structure is observed at India Pesticides and Shivalik Rasayan.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Meghmani Organi. at -21.90%, while the lowest is Heranba Inds at -51.21%. Advance Agrolife's 1-year return is not available for comparison. Additionally, peers with a negative six-month return include Astec Lifescienc, Heranba Inds, and Crop Life Scienc.

How big is Advance Agrolife?

As of 31st August, Advance Agrolife Ltd has a market capitalization of 749.00 Cr, with recent net sales of 799.55 Cr and a net profit of 48.90 Cr. Shareholder's funds are 100.87 Cr, and total assets amount to 350.71 Cr as of March 2025.

As of 31st August, Advance Agrolife Ltd has a market capitalization of 749.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Advance Agrolife reported Net Sales of 799.55 Cr and a Net Profit of 48.90 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 100.87 Cr and Total Assets of 350.71 Cr.

Which are the latest news on Advance Agrolife?

Should I buy, sell or hold Advance Agrolife Ltd?

When is the next results date for Advance Agrolife Ltd?

The next results date for Advance Agrolife Ltd is August 6, 2026.

The next results date for Advance Agrolife Ltd is scheduled for August 6, 2026.

Are Advance Agrolife Ltd latest results good or bad?

Advance Agrolife Ltd's latest results show strong profit growth, with a 421.68% increase in net profit for Q4 FY26, but revenue has declined sequentially, raising concerns about sustainability. Additionally, cash flow issues and reduced institutional investor participation suggest caution regarding the company's long-term prospects.

Advance Agrolife Ltd's latest results present a mixed picture. On one hand, the company reported a significant increase in net profit for Q4 FY26, reaching ₹7.46 crores, which is up 421.68% year-on-year and 147.90% quarter-on-quarter. This indicates strong profitability improvement and operational efficiency, as reflected in the expansion of the PAT margin to 6.02%, up from 1.59% a year prior.<BR><BR>However, the revenue figures tell a different story. The company recorded revenue of ₹123.88 crores, which represents a robust year-on-year growth of 37.90%. Yet, it also experienced a sequential decline of 6.60% from the previous quarter, highlighting volatility in revenue generation. This inconsistency raises concerns about the sustainability of the recent profit growth.<BR><BR>Additionally, while operating margins improved to 10.80%, the company faces challenges related to cash flow generation, with operating cash flow dropping significantly to ₹5.00 crores from ₹14.00 crores in the prior year. Furthermore, there has been a notable decline in institutional investor participation, which could signal caution among sophisticated investors regarding the company's long-term prospects.<BR><BR>In summary, while the profit growth is commendable, the underlying issues with revenue consistency and cash flow generation, along with declining institutional confidence, suggest that the overall results may not be as favorable as the profit figures alone would indicate. Investors should consider these factors when evaluating the company's performance.